Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Qorvo (QRVO) Financials

Qorvo logo
$106.43 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$106.20 -0.23 (-0.22%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Qorvo

Annual Income Statements for Qorvo

This table shows Qorvo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Consolidated Net Income / (Loss)
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Net Income / (Loss) Continuing Operations
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Total Pre-Tax Income
-2.86 27 17 92 395 807 1,181 125 74 66 398
Total Operating Income
12 88 70 216 423 907 1,226 183 92 96 411
Total Gross Profit
1,050 1,136 1,147 1,195 1,322 1,884 2,286 1,297 1,488 1,536 1,688
Total Revenue
2,611 3,033 2,974 3,090 3,239 4,015 4,646 3,569 3,770 3,719 3,679
Operating Revenue
2,611 3,033 2,974 3,090 3,239 4,015 4,646 3,569 3,770 3,719 3,679
Total Cost of Revenue
1,561 1,897 1,827 1,895 1,917 2,132 2,360 2,272 2,281 2,183 1,990
Operating Cost of Revenue
1,561 1,897 1,827 1,895 1,917 2,132 2,360 2,272 2,281 2,183 1,990
Total Operating Expenses
1,038 1,047 1,077 979 899 977 1,060 1,114 1,397 1,440 1,277
Selling, General & Admin Expense
534 546 632 528 414 407 388 241 276 268 253
Marketing Expense
- - - - - - - 211 217 232 215
Research & Development Expense
449 471 445 450 484 570 624 650 682 748 726
Impairment Charge
- - - - - - 48 12 221 193 82
Total Other Income / (Expense), net
-15 -61 -53 -125 -28 -99 -45 -59 -18 -30 -13
Interest Expense
23 59 60 44 60 75 63 68 69 78 73
Other Income / (Expense), net
6.42 -3.09 -0.61 -81 32 -24 18 9.92 51 49 60
Income Tax Expense
26 44 57 -41 61 74 148 21 144 10 59
Basic Earnings per Share
($0.20) ($0.13) ($0.32) $1.07 $2.86 $6.43 $9.38 $1.01 ($0.72) $0.59 $3.66
Weighted Average Basic Shares Outstanding
141.94M 127.12M 126.95M 124.53M 117.01M 114.03M 110.20M 102.21M 97.56M 94.59M 92.59M
Diluted Earnings per Share
($0.20) ($0.13) ($0.32) $1.05 $2.80 $6.32 $9.26 $1.00 ($0.72) $0.58 $3.62
Weighted Average Diluted Shares Outstanding
141.94M 127.12M 126.95M 127.36M 119.29M 116.02M 111.55M 103.02M 97.56M 95.45M 93.55M
Weighted Average Basic & Diluted Shares Outstanding
144.20M 127.40M 125.90M 124.40M 114.73M 112.59M 106.03M 98.74M 95.63M 93.03M 88.01M

Quarterly Income Statements for Qorvo

This table shows Qorvo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders
97 -127 2.74 0.41 -17 41 31 26 120 164 30
Consolidated Net Income / (Loss)
97 -127 2.74 0.41 -17 41 31 26 120 164 30
Net Income / (Loss) Continuing Operations
97 -127 2.74 0.41 -17 41 31 26 120 164 30
Total Pre-Tax Income
140 -44 30 -0.72 2.50 49 15 32 155 190 22
Total Operating Income
151 -42 30 4.61 9.68 53 28 30 158 192 32
Total Gross Profit
490 388 382 332 445 391 367 332 497 464 395
Total Revenue
1,103 1,074 941 887 1,047 916 869 819 1,059 993 808
Operating Revenue
1,103 1,074 941 887 1,047 916 869 819 1,059 993 808
Total Cost of Revenue
614 686 559 554 601 525 503 487 561 529 413
Operating Cost of Revenue
614 686 559 554 601 525 503 487 561 529 413
Total Operating Expenses
338 429 352 328 436 338 338 302 339 272 364
Selling, General & Admin Expense
115 92 -49 80 61 103 -170 66 81 45 61
Marketing Expense
- - - 60 60 57 - 57 60 49 50
Research & Development Expense
175 164 180 188 201 179 180 179 198 178 170
Total Other Income / (Expense), net
-12 -2.22 -0.46 -5.33 -7.17 -4.13 -13 1.60 -2.59 -2.34 -9.82
Interest Expense
17 18 17 17 23 19 20 19 18 18 18
Other Income / (Expense), net
5.21 15 17 12 15 15 6.99 20 16 16 8.02
Income Tax Expense
42 83 27 -1.14 20 7.63 -16 6.09 35 26 -8.04
Basic Earnings per Share
$1.00 ($1.31) $0.03 $0.00 ($0.18) $0.44 $0.33 $0.28 $1.29 $1.77 $0.32
Weighted Average Basic Shares Outstanding
97.95M 97.15M 97.56M 95.47M 94.89M 94.34M 94.59M 92.92M 92.80M 92.59M 92.59M
Diluted Earnings per Share
$0.99 ($1.31) $0.04 $0.00 ($0.18) $0.43 $0.33 $0.27 $1.28 $1.75 $0.32
Weighted Average Diluted Shares Outstanding
98.59M 97.15M 97.56M 96.51M 94.89M 95.03M 95.45M 93.77M 93.79M 93.57M 93.55M
Weighted Average Basic & Diluted Shares Outstanding
97.35M 96.55M 95.63M 94.86M 94.53M 93.40M 93.03M 92.65M 92.40M 92.71M 88.01M

Annual Cash Flow Statements for Qorvo

This table details how cash moves in and out of Qorvo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
Net Change in Cash & Equivalents
126 120 381 -215 4.23 683 -426 -164 240 -26 198
Net Cash From Operating Activities
688 777 853 810 946 1,302 1,049 843 833 622 809
Net Cash From Continuing Operating Activities
688 777 853 810 946 1,302 1,049 843 833 622 809
Net Income / (Loss) Continuing Operations
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Consolidated Net Income / (Loss)
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Depreciation Expense
180 210 174 209 222 203 211 206 193 163 151
Amortization Expense
495 495 540 454 247 253 150 132 128 134 111
Non-Cash Adjustments To Reconcile Net Income
136 89 113 178 51 157 132 345 342 329 218
Changes in Operating Assets and Liabilities, net
-94 -0.01 64 -164 91 -44 -477 56 240 -59 -11
Net Cash From Investing Activities
-279 -490 -277 -248 -1,106 -219 -596 -153 -136 37 -44
Net Cash From Continuing Investing Activities
-279 -490 -277 -248 -1,106 -219 -596 -153 -136 37 -44
Purchase of Property, Plant & Equipment
-316 -553 -270 -221 -164 -187 -213 -159 -127 -138 -129
Acquisitions
0.00 -118 0.00 0.00 -946 -47 -389 -0.10 -83 -0.79 0.00
Sale of Property, Plant & Equipment
- - - - - - 0.90 1.85 50 7.06 52
Divestitures
- - - - - - - 0.00 20 173 21
Other Investing Activities, net
-13 -5.98 -7.57 -27 4.41 15 5.75 3.79 4.19 -5.23 12
Net Cash From Financing Activities
-283 -166 -197 -777 166 -402 -876 -853 -460 -684 -567
Net Cash From Continuing Financing Activities
-283 -166 -197 -777 166 -402 -876 -853 -460 -684 -567
Repayment of Debt
-189 0.00 -110 -1,060 -6.72 -1,098 -207 -0.69 -69 -463 -26
Repurchase of Common Equity
-1,300 -209 -220 -638 -515 -515 -1,152 -862 -400 -356 -533
Issuance of Common Equity
52 59 57 41 50 43 38 33 37 36 35
Other Financing Activities, net
-21 -16 -25 -25 -22 -39 -53 -23 -27 99 -44
Cash Interest Paid
2.16 71 70 56 49 81 59 66 55 76 73

Quarterly Cash Flow Statements for Qorvo

This table details how cash moves in and out of Qorvo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Change in Cash & Equivalents
-38 385 -43 33 14 -327 252 144 -62 215 -99
Net Cash From Operating Activities
93 493 202 81 128 214 199 183 84 265 276
Net Cash From Continuing Operating Activities
93 493 202 81 128 214 199 183 84 265 276
Net Income / (Loss) Continuing Operations
97 -127 2.74 0.41 -17 41 31 26 120 164 30
Consolidated Net Income / (Loss)
97 -127 2.74 0.41 -17 41 31 26 120 164 30
Depreciation Expense
49 48 46 41 40 41 40 39 39 37 36
Amortization Expense
30 31 36 35 36 32 30 28 28 28 27
Non-Cash Adjustments To Reconcile Net Income
105 195 31 42 135 28 130 42 40 27 109
Changes in Operating Assets and Liabilities, net
-189 346 87 -38 -65 71 -33 47 -143 9.00 75
Net Cash From Investing Activities
-20 0.90 -113 -17 -35 -7.07 96 -33 -33 4.28 18
Net Cash From Continuing Investing Activities
-20 0.90 -113 -17 -35 -7.07 96 -33 -33 4.28 18
Purchase of Property, Plant & Equipment
-29 -26 -33 -38 -33 -38 -29 -38 -42 -28 -21
Sale of Property, Plant & Equipment
5.59 0.15 2.10 0.00 1.30 0.98 4.66 0.00 - - 52
Other Investing Activities, net
2.76 27 0.41 -35 -3.11 30 2.74 4.21 9.12 11 -12
Net Cash From Financing Activities
-109 -114 -132 -30 -80 -532 -43 -6.94 -113 -54 -392
Net Cash From Continuing Financing Activities
-109 -114 -132 -30 -80 -532 -43 -6.94 -113 -54 -392
Repayment of Debt
-0.03 -18 -41 -34 -3.36 -421 -4.97 -5.17 -4.50 -9.13 -6.93
Repurchase of Common Equity
-100 -100 -100 -125 -81 -100 -50 -50 -65 -17 -400
Issuance of Common Equity
11 5.32 11 9.51 12 3.35 11 9.83 12 3.59 10
Other Financing Activities, net
-20 -0.85 -0.79 120 -6.51 -14 0.19 38 -55 -31 4.50

Annual Balance Sheets for Qorvo

This table presents Qorvo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
Total Assets
6,597 6,522 6,382 5,808 6,561 7,221 7,509 6,692 6,555 5,933 5,826
Total Current Assets
1,509 1,462 1,844 1,685 1,691 2,484 2,450 2,030 2,446 2,167 2,306
Cash & Equivalents
426 545 926 711 715 1,398 973 809 1,029 1,021 1,219
Accounts Receivable
364 423 391 400 382 485 601 331 427 398 399
Inventories, net
428 430 472 512 517 508 756 797 711 641 554
Prepaid Expenses
64 36 24 26 38 42 50 47 41 33 37
Other Current Assets
41 26 31 36 38 52 71 47 79 75 98
Other Current Nonoperating Assets
- - - - - - - 0.00 159 0.00 0.00
Plant, Property, & Equipment, net
1,047 1,392 1,374 1,367 1,259 1,266 1,254 1,150 871 802 710
Total Noncurrent Assets
4,041 3,669 3,164 2,757 3,611 3,472 3,806 3,512 3,238 2,964 2,809
Long-Term Investments
26 35 64 98 23 35 31 20 23 23 16
Goodwill
2,136 2,174 2,174 2,174 2,614 2,643 2,776 2,761 2,535 2,390 2,353
Intangible Assets
1,813 1,401 860 408 809 611 675 538 509 273 122
Other Noncurrent Operating Assets
66 59 66 77 165 182 324 193 170 277 318
Total Liabilities & Shareholders' Equity
6,597 6,522 6,382 5,808 6,561 7,221 7,509 6,692 6,555 5,933 5,826
Total Liabilities
1,597 1,626 1,606 1,448 2,268 2,592 2,956 2,789 2,998 2,541 2,481
Total Current Liabilities
374 419 441 436 539 682 675 556 1,230 783 713
Short-Term Debt
- - - 0.08 6.89 - - 0.31 439 0.00 0.00
Accounts Payable
205 216 213 233 247 314 328 211 253 261 243
Accrued Expenses
138 171 167 161 218 255 240 222 337 288 248
Other Current Liabilities
31 32 61 42 67 113 107 122 113 235 222
Other Current Nonoperating Liabilities
- - - - - - - 0.00 88 0.00 0.00
Total Noncurrent Liabilities
1,223 1,207 1,165 1,013 1,729 1,910 2,281 2,233 1,768 1,758 1,769
Long-Term Debt
988 989 983 921 1,567 1,743 2,047 2,048 1,549 1,549 1,549
Other Noncurrent Operating Liabilities
83 86 118 92 162 168 234 185 219 208 219
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,000 4,897 4,776 4,360 4,293 4,629 4,553 3,903 3,556 3,392 3,344
Total Preferred & Common Equity
5,000 4,897 4,776 4,360 4,293 4,629 4,553 3,903 3,556 3,392 3,344
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,000 4,897 4,776 4,360 4,293 4,629 4,553 3,903 3,556 3,392 3,344
Common Stock
5,443 5,357 5,237 4,687 4,290 4,245 4,036 3,821 3,651 3,431 3,301
Retained Earnings
-440 -456 -459 -321 0.00 355 512 84 -90 -34 39
Accumulated Other Comprehensive Income / (Loss)
-3.13 -4.31 -2.75 -6.62 2.29 30 5.23 -3.18 -5.10 -5.01 4.06

Quarterly Balance Sheets for Qorvo

This table presents Qorvo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 6/28/2025 9/27/2025 12/27/2025
Total Assets
6,692 6,687 6,719 6,699 6,555 6,447 6,503 5,963 5,998 6,096 6,164
Total Current Assets
2,030 2,088 2,263 2,428 2,446 2,378 2,532 2,097 2,246 2,377 2,483
Cash & Equivalents
809 744 707 1,072 1,029 1,082 1,096 769 1,165 1,103 1,319
Accounts Receivable
331 327 621 515 427 440 594 439 343 560 520
Inventories, net
797 917 840 727 711 727 694 656 638 605 530
Prepaid Expenses
47 49 49 40 41 30 38 38 31 34 35
Other Current Assets
47 49 46 75 79 99 110 78 69 74 79
Other Current Nonoperating Assets
0.00 - - - 159 0.00 0.00 116 0.00 0.00 0.00
Plant, Property, & Equipment, net
1,150 1,088 1,061 1,039 871 867 847 821 794 781 755
Total Noncurrent Assets
3,512 3,511 3,394 3,232 3,238 3,202 3,124 3,045 2,957 2,938 2,925
Long-Term Investments
20 27 26 25 23 26 25 26 22 17 19
Goodwill
2,761 2,761 2,708 2,540 2,535 2,533 2,438 2,437 2,390 2,390 2,390
Intangible Assets
538 507 473 500 509 474 446 332 252 224 197
Other Noncurrent Operating Assets
193 216 187 166 170 170 216 250 293 306 320
Total Liabilities & Shareholders' Equity
6,692 6,687 6,719 6,699 6,555 6,447 6,503 5,963 5,998 6,096 6,164
Total Liabilities
2,789 2,874 2,901 3,061 2,998 2,961 3,093 2,583 2,560 2,586 2,466
Total Current Liabilities
556 639 672 1,280 1,230 1,217 1,334 808 798 805 676
Short-Term Debt
0.31 - - 480 439 412 412 0.00 0.00 0.00 0.00
Accounts Payable
211 294 275 283 253 304 322 283 280 285 241
Accrued Expenses
222 264 304 327 337 300 354 268 252 287 225
Other Current Liabilities
122 80 93 190 113 200 246 227 266 232 210
Other Current Nonoperating Liabilities
0.00 - - - 88 0.00 0.00 29 0.00 0.00 0.00
Total Noncurrent Liabilities
2,233 2,235 2,229 1,781 1,768 1,745 1,759 1,775 1,762 1,781 1,790
Long-Term Debt
2,048 2,048 2,049 1,550 1,549 1,549 1,549 1,549 1,549 1,549 1,549
Other Noncurrent Operating Liabilities
185 187 181 230 219 195 210 226 213 232 241
Total Equity & Noncontrolling Interests
3,903 3,812 3,817 3,638 3,556 3,486 3,410 3,380 3,437 3,510 3,698
Total Preferred & Common Equity
3,903 3,812 3,817 3,638 3,556 3,486 3,410 3,380 3,437 3,510 3,698
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,903 3,812 3,817 3,638 3,556 3,486 3,410 3,380 3,437 3,510 3,698
Common Stock
3,821 3,816 3,796 3,731 3,651 3,581 3,516 3,456 3,439 3,431 3,465
Retained Earnings
84 0.00 35 -92 -90 -89 -107 -65 -8.39 73 227
Accumulated Other Comprehensive Income / (Loss)
-3.18 -4.04 -14 0.10 -5.10 -6.03 1.15 -10 6.36 5.48 6.37

Annual Metrics And Ratios for Qorvo

This table displays calculated financial ratios and metrics derived from Qorvo's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
DEI Shares Outstanding
- - - - - - - - - - 92,705,679.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 92,705,679.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.66
Growth Metrics
- - - - - - - - - - -
Revenue Growth
52.59% 16.16% -1.95% 3.93% 4.82% 23.96% 15.70% -23.17% 5.61% -1.34% -1.09%
EBITDA Growth
103.93% 13.87% -0.72% 1.91% 15.72% 44.81% 19.96% -66.87% -12.82% -4.89% 66.37%
EBIT Growth
-84.96% 362.16% -18.00% 94.84% 235.52% 93.77% 41.00% -84.48% -26.04% 1.00% 226.85%
NOPAT Growth
-95.78% -737.41% -209.27% 290.09% 14.08% 130.03% 30.22% -85.87% -157.83% 191.96% 334.37%
Net Income Growth
-114.69% 42.60% -143.31% 430.43% 151.14% 119.43% 40.86% -90.02% -168.17% 179.09% 509.53%
EPS Growth
-109.48% 35.00% -146.15% 428.13% 166.67% 125.71% 46.52% -89.20% -172.00% 180.56% 524.14%
Operating Cash Flow Growth
125.09% 12.92% 9.74% -4.94% 16.69% 37.67% -19.40% -19.63% -1.19% -25.32% 29.96%
Free Cash Flow Firm Growth
105.78% -103.26% 4,105.23% 64.85% -148.98% 438.88% -59.11% 50.97% -2.05% -1.42% -2.60%
Invested Capital Growth
-4.90% -0.83% -10.10% -6.23% 14.70% -3.72% 13.32% -8.48% -13.69% -11.85% -6.13%
Revenue Q/Q Growth
-1.02% 1.17% 0.76% 0.50% 3.41% 7.64% 2.05% -13.00% 8.91% -1.89% -1.64%
EBITDA Q/Q Growth
19.10% -0.99% -2.10% 5.94% 2.34% 15.32% -2.04% -45.95% 95.15% -4.87% -0.51%
EBIT Q/Q Growth
119.20% -29.27% -8.38% 267.74% 5.40% 31.32% -2.91% -69.82% 266.51% -7.44% 0.93%
NOPAT Q/Q Growth
112.08% 71.75% -278.13% 271.74% 2.47% 38.81% -6.37% -70.32% 1.59% 146.26% -1.31%
Net Income Q/Q Growth
-1,668.52% 82.87% -243.27% 125.23% -3.22% 51.18% -7.72% -77.27% 66.75% 106.10% -0.48%
EPS Q/Q Growth
58.33% 82.19% -252.38% 123.40% -2.78% 51.92% -6.18% -76.58% 65.22% 100.00% -0.28%
Operating Cash Flow Q/Q Growth
3.17% 12.67% 1.41% -8.12% 2.94% 16.93% -5.16% -24.96% 19.66% -0.51% 10.54%
Free Cash Flow Firm Q/Q Growth
0.00% 88.85% -9.24% 13.41% -337.19% 166.13% -6.82% -32.58% 0.85% 8.44% 19.73%
Invested Capital Q/Q Growth
-1.45% -0.31% -4.73% -1.75% 7.43% -0.97% -1.60% -2.80% -3.30% -3.71% -6.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.20% 37.44% 38.57% 38.68% 40.81% 46.91% 49.21% 36.34% 39.49% 41.29% 45.89%
EBITDA Margin
26.56% 26.04% 26.36% 25.85% 28.54% 33.34% 34.57% 14.90% 12.30% 11.86% 19.95%
Operating Margin
0.46% 2.90% 2.36% 7.00% 13.07% 22.58% 26.39% 5.13% 2.43% 2.57% 11.18%
EBIT Margin
0.70% 2.80% 2.34% 4.39% 14.06% 21.98% 26.79% 5.41% 3.79% 3.88% 12.82%
Profit (Net Income) Margin
-1.10% -0.55% -1.35% 4.31% 10.32% 18.27% 22.24% 2.89% -1.87% 1.50% 9.22%
Tax Burden Percent
1,007.86% -60.64% -234.98% 145.03% 84.62% 90.86% 87.49% 82.77% -95.60% 84.39% 85.11%
Interest Burden Percent
-15.57% 32.13% 24.61% 67.62% 86.74% 91.48% 94.91% 64.54% 51.51% 45.69% 84.49%
Effective Tax Rate
0.00% 160.64% 334.98% -45.03% 15.38% 9.14% 12.51% 17.23% 195.60% 15.61% 14.89%
Return on Invested Capital (ROIC)
0.15% -1.00% -3.28% 6.79% 7.46% 16.36% 20.36% 2.83% -1.84% 1.94% 9.27%
ROIC Less NNEP Spread (ROIC-NNEP)
37.50% 8.72% 58.89% -335.39% 2.44% 0.63% 14.54% -1.45% -0.17% -1.71% 6.53%
Return on Net Nonoperating Assets (RNNOA)
-0.67% 0.67% 2.45% -3.88% 0.27% 0.08% 2.14% -0.39% -0.05% -0.34% 0.79%
Return on Equity (ROE)
-0.52% -0.33% -0.83% 2.91% 7.73% 16.44% 22.51% 2.44% -1.89% 1.60% 10.06%
Cash Return on Invested Capital (CROIC)
5.17% -0.17% 7.36% 13.23% -6.24% 20.15% 7.87% 11.68% 12.86% 14.54% 15.59%
Operating Return on Assets (OROA)
0.27% 1.30% 1.08% 2.23% 7.37% 12.81% 16.90% 2.72% 2.16% 2.31% 8.02%
Return on Assets (ROA)
-0.43% -0.25% -0.62% 2.18% 5.41% 10.65% 14.03% 1.45% -1.06% 0.89% 5.77%
Return on Common Equity (ROCE)
-0.52% -0.33% -0.83% 2.91% 7.73% 16.44% 22.51% 2.44% -1.89% 1.60% 10.06%
Return on Equity Simple (ROE_SIMPLE)
-0.58% -0.34% -0.84% 3.05% 7.79% 15.85% 22.70% 2.64% -1.98% 1.64% 0.00%
Net Operating Profit after Tax (NOPAT)
8.38 -53 -165 314 358 824 1,073 152 -88 81 350
NOPAT Margin
0.32% -1.76% -5.55% 10.16% 11.06% 20.52% 23.09% 4.25% -2.33% 2.17% 9.52%
Net Nonoperating Expense Percent (NNEP)
-37.35% -9.73% -62.17% 342.18% 5.02% 15.74% 5.82% 4.28% -1.66% 3.65% 2.74%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 1.63% 7.16%
Cost of Revenue to Revenue
59.80% 62.56% 61.43% 61.33% 59.19% 53.09% 50.79% 63.67% 60.51% 58.71% 54.11%
SG&A Expenses to Revenue
20.46% 17.99% 21.24% 17.09% 12.79% 10.12% 8.36% 12.65% 13.08% 7.20% 6.87%
R&D to Revenue
17.19% 15.53% 14.97% 14.58% 14.96% 14.21% 13.42% 18.21% 18.10% 20.11% 19.74%
Operating Expenses to Revenue
39.74% 34.54% 36.21% 31.67% 27.74% 24.33% 22.82% 31.20% 37.06% 38.72% 34.71%
Earnings before Interest and Taxes (EBIT)
18 85 70 136 455 883 1,244 193 143 144 471
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
693 790 784 799 924 1,339 1,606 532 464 441 734
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.39 1.77 1.87 2.02 2.17 4.72 2.89 2.60 3.12 1.97 2.14
Price to Tangible Book Value (P/TBV)
6.63 6.56 5.12 4.95 10.74 15.88 11.95 16.79 21.64 9.16 8.25
Price to Revenue (P/Rev)
2.67 2.86 3.00 2.85 2.88 5.44 2.84 2.84 2.94 1.80 1.95
Price to Earnings (P/E)
0.00 0.00 0.00 66.16 27.92 29.78 12.75 98.36 0.00 120.07 21.15
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 1.51% 3.58% 3.36% 7.84% 1.02% 0.00% 0.83% 4.73%
Enterprise Value to Invested Capital (EV/IC)
1.37 1.71 1.87 1.99 1.98 4.49 2.54 2.22 2.72 1.84 2.05
Enterprise Value to Revenue (EV/Rev)
2.80 2.99 2.99 2.89 3.14 5.52 3.06 3.18 3.19 1.93 2.03
Enterprise Value to EBITDA (EV/EBITDA)
10.55 11.50 11.36 11.17 11.00 16.55 8.85 21.37 25.92 16.28 10.20
Enterprise Value to EBIT (EV/EBIT)
397.97 106.83 127.81 65.71 22.33 25.11 11.43 58.86 84.19 49.80 15.88
Enterprise Value to NOPAT (EV/NOPAT)
873.41 0.00 0.00 28.41 28.40 26.90 13.26 74.97 0.00 89.09 21.37
Enterprise Value to Operating Cash Flow (EV/OCF)
10.64 11.69 10.45 11.01 10.76 17.02 13.55 13.48 14.43 11.54 9.26
Enterprise Value to Free Cash Flow (EV/FCFF)
25.79 0.00 24.02 14.60 0.00 21.84 34.28 18.15 19.60 11.88 12.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.20 0.20 0.21 0.21 0.37 0.38 0.45 0.52 0.56 0.46 0.46
Long-Term Debt to Equity
0.20 0.20 0.21 0.21 0.37 0.38 0.45 0.52 0.44 0.46 0.46
Financial Leverage
-0.02 0.08 0.04 0.01 0.11 0.13 0.15 0.27 0.28 0.20 0.12
Leverage Ratio
1.21 1.33 1.33 1.33 1.43 1.54 1.60 1.68 1.78 1.80 1.75
Compound Leverage Factor
-0.19 0.43 0.33 0.90 1.24 1.41 1.52 1.08 0.91 0.82 1.47
Debt to Total Capital
16.50% 16.81% 17.07% 17.44% 26.83% 27.35% 31.02% 34.42% 35.86% 31.35% 31.66%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.12% 0.00% 0.00% 0.01% 7.91% 0.00% 0.00%
Long-Term Debt to Total Capital
16.50% 16.81% 17.07% 17.44% 26.71% 27.35% 31.02% 34.41% 27.94% 31.35% 31.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
83.50% 83.19% 82.93% 82.56% 73.17% 72.65% 68.98% 65.58% 64.14% 68.65% 68.34%
Debt to EBITDA
1.42 1.25 1.25 1.15 1.70 1.30 1.27 3.85 4.29 3.51 2.11
Net Debt to EBITDA
0.50 0.52 -0.01 0.14 0.91 0.23 0.65 2.29 2.02 1.14 0.43
Long-Term Debt to EBITDA
1.42 1.25 1.25 1.15 1.70 1.30 1.27 3.85 3.34 3.51 2.11
Debt to NOPAT
117.95 -18.52 -5.95 2.93 4.40 2.12 1.91 13.51 -22.68 19.22 4.42
Net Debt to NOPAT
41.71 -7.64 0.04 0.36 2.34 0.38 0.97 8.04 -10.67 6.26 0.90
Long-Term Debt to NOPAT
117.95 -18.52 -5.95 2.93 4.38 2.12 1.91 13.51 -17.67 19.22 4.42
Altman Z-Score
3.14 3.80 3.99 4.44 3.40 6.39 4.22 3.09 3.07 2.56 2.97
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.04 3.49 4.18 3.87 3.14 3.64 3.63 3.65 1.99 2.77 3.24
Quick Ratio
2.61 2.31 2.98 2.55 2.04 2.76 2.33 2.05 1.18 1.81 2.27
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
284 -9.26 371 611 -299 1,014 415 626 613 605 589
Operating Cash Flow to CapEx
217.96% 140.55% 315.94% 366.79% 576.25% 696.33% 493.60% 536.73% 1,072.56% 476.63% 1,045.30%
Free Cash Flow to Firm to Interest Expense
12.17 -0.16 6.23 13.90 -4.96 13.49 6.55 9.15 8.86 7.72 8.05
Operating Cash Flow to Interest Expense
29.50 13.19 14.32 18.43 15.66 17.31 16.57 12.32 12.03 7.94 11.06
Operating Cash Flow Less CapEx to Interest Expense
15.97 3.81 9.79 13.41 12.94 14.83 13.21 10.02 10.91 6.28 10.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.39 0.46 0.46 0.51 0.52 0.58 0.63 0.50 0.57 0.60 0.63
Accounts Receivable Turnover
7.02 7.71 7.31 7.82 8.28 9.26 8.56 7.66 9.94 9.01 9.24
Inventory Turnover
4.03 4.42 4.05 3.85 3.73 4.16 3.73 2.93 3.03 3.23 3.33
Fixed Asset Turnover
2.71 2.49 2.15 2.26 2.47 3.18 3.69 2.97 3.73 4.45 4.86
Accounts Payable Turnover
8.05 9.00 8.51 8.49 7.98 7.60 7.35 8.44 9.84 8.50 7.91
Days Sales Outstanding (DSO)
51.97 47.36 49.96 46.70 44.08 39.40 42.65 47.66 36.72 40.49 39.51
Days Inventory Outstanding (DIO)
90.53 82.54 90.20 94.77 97.94 87.75 97.73 124.67 120.58 112.97 109.54
Days Payable Outstanding (DPO)
45.34 40.56 42.91 43.00 45.71 48.01 49.64 43.26 37.10 42.93 46.17
Cash Conversion Cycle (CCC)
97.16 89.34 97.25 98.47 96.31 79.14 90.74 129.07 120.21 110.53 102.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,349 5,305 4,769 4,472 5,129 4,939 5,597 5,122 4,421 3,897 3,658
Invested Capital Turnover
0.48 0.57 0.59 0.67 0.67 0.80 0.88 0.67 0.79 0.89 0.97
Increase / (Decrease) in Invested Capital
-275 -44 -536 -297 657 -191 658 -475 -701 -524 -239
Enterprise Value (EV)
7,317 9,078 8,905 8,920 10,171 22,158 14,219 11,365 12,022 7,182 7,485
Market Capitalization
6,968 8,670 8,911 8,808 9,335 21,848 13,176 10,146 11,087 6,678 7,171
Book Value per Share
$36.47 $38.72 $37.75 $35.51 $37.11 $40.87 $41.99 $39.07 $36.84 $36.32 $36.07
Tangible Book Value per Share
$7.67 $10.46 $13.77 $14.48 $7.52 $12.14 $10.17 $6.05 $5.31 $7.81 $9.38
Total Capital
5,988 5,886 5,759 5,281 5,867 6,372 6,600 5,951 5,544 4,942 4,893
Total Debt
988 989 983 921 1,574 1,743 2,047 2,048 1,988 1,549 1,549
Total Long-Term Debt
988 989 983 921 1,567 1,743 2,047 2,048 1,549 1,549 1,549
Net Debt
349 408 -6.51 112 837 309 1,043 1,219 936 505 314
Capital Expenditures (CapEx)
316 553 270 221 164 187 213 157 78 131 77
Debt-free, Cash-free Net Working Capital (DFCFNWC)
523 497 476 538 443 404 802 666 625 363 375
Debt-free Net Working Capital (DFNWC)
1,135 1,043 1,403 1,249 1,158 1,802 1,775 1,474 1,655 1,384 1,594
Net Working Capital (NWC)
1,135 1,043 1,403 1,249 1,151 1,802 1,775 1,474 1,216 1,384 1,594
Net Nonoperating Expense (NNE)
37 -37 -125 181 24 90 39 48 -17 25 11
Net Nonoperating Obligations (NNO)
349 408 -6.51 112 837 309 1,043 1,219 865 505 314
Total Depreciation and Amortization (D&A)
675 705 714 663 469 456 361 339 321 297 262
Debt-free, Cash-free Net Working Capital to Revenue
20.02% 16.40% 16.02% 17.42% 13.69% 10.07% 17.27% 18.65% 16.59% 9.76% 10.18%
Debt-free Net Working Capital to Revenue
43.49% 34.39% 47.17% 40.43% 35.76% 44.88% 38.20% 41.31% 43.90% 37.22% 43.32%
Net Working Capital to Revenue
43.49% 34.39% 47.17% 40.42% 35.55% 44.88% 38.20% 41.30% 32.26% 37.22% 43.32%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.20) $0.00 ($0.32) $1.07 $2.86 $6.43 $9.38 $1.01 ($0.72) $0.59 $3.66
Adjusted Weighted Average Basic Shares Outstanding
141.94M 0.00 126.95M 124.53M 117.01M 114.03M 110.20M 102.21M 97.56M 94.59M 92.59M
Adjusted Diluted Earnings per Share
($0.20) $0.00 ($0.32) $1.05 $2.80 $6.32 $9.26 $1.00 ($0.72) $0.58 $3.62
Adjusted Weighted Average Diluted Shares Outstanding
141.94M 0.00 126.95M 127.36M 119.29M 116.02M 111.55M 103.02M 97.56M 95.45M 93.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
127.53M 0.00 126.49M 119.15M 114.73M 112.59M 106.03M 98.74M 95.63M 93.03M 88.01M
Normalized Net Operating Profit after Tax (NOPAT)
8.38 62 49 152 358 824 1,115 162 219 243 420
Normalized NOPAT Margin
0.32% 2.03% 1.65% 4.90% 11.06% 20.52% 23.99% 4.54% 5.81% 6.54% 11.43%
Pre Tax Income Margin
-0.11% 0.90% 0.58% 2.97% 12.20% 20.11% 25.42% 3.49% 1.95% 1.77% 10.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.79 1.44 1.17 3.09 7.54 11.74 19.65 2.82 2.06 1.84 6.45
NOPAT to Interest Expense
0.36 -0.91 -2.77 7.14 5.93 10.95 16.94 2.21 -1.27 1.03 4.79
EBIT Less CapEx to Interest Expense
-12.75 -7.94 -3.36 -1.94 4.82 9.25 16.29 0.53 0.94 0.17 5.39
NOPAT Less CapEx to Interest Expense
-13.18 -10.29 -7.30 2.12 3.21 8.47 13.58 -0.08 -2.39 -0.64 3.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-4,506.88% -1,264.39% -545.84% 479.30% 154.08% 70.21% 111.51% 835.42% -568.89% 640.72% 157.10%

Quarterly Metrics And Ratios for Qorvo

This table displays calculated financial ratios and metrics derived from Qorvo's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
DEI Shares Outstanding
- - - - - - - - - - 92,705,679.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 92,705,679.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.32
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.71% 44.48% 48.73% 36.17% -5.16% -14.67% -7.60% -7.66% 1.15% 8.36% -7.04%
EBITDA Growth
-32.30% -46.53% 231.83% 98.58% -57.11% 168.51% -17.57% 27.47% 137.49% 93.34% -3.54%
EBIT Growth
-40.62% -283.40% 125.74% 147.56% -83.98% 357.73% -24.76% 208.30% 591.63% 207.66% 12.28%
NOPAT Growth
-47.07% -576.22% 102.10% 109.57% -163.71% 253.81% 1,993.08% 653.75% 280.43% 271.08% -25.71%
Net Income Growth
-48.33% -696.80% 101.98% 100.95% -117.89% 132.51% 1,046.80% 6,082.13% 785.99% 297.52% -5.21%
EPS Growth
-45.60% -718.75% 103.05% 100.00% -118.18% 132.82% 725.00% 0.00% 811.11% 306.98% -3.03%
Operating Cash Flow Growth
-65.22% 107.68% 209.19% 80.63% 37.46% -56.57% -1.56% 125.62% -34.30% 23.98% 38.70%
Free Cash Flow Firm Growth
627.87% 57.53% 105.59% 122.79% 103.38% -14.75% -17.28% -25.05% -46.82% -46.78% -51.57%
Invested Capital Growth
-5.44% -13.23% -13.69% -14.73% -17.20% -11.48% -11.85% -12.45% -7.34% -3.39% -6.13%
Revenue Q/Q Growth
69.46% -2.69% -12.37% -5.77% 18.03% -12.44% -5.11% -5.83% 29.28% -6.19% -18.60%
EBITDA Q/Q Growth
406.34% -77.68% 144.20% -28.04% 9.36% 39.73% -25.03% 11.27% 103.75% 13.76% -62.60%
EBIT Q/Q Growth
555.08% -116.73% 278.54% -65.02% 53.30% 169.16% -47.88% 43.35% 243.91% 19.73% -80.98%
NOPAT Q/Q Growth
413.93% -127.51% 109.55% 16.06% -2,190.21% 166.41% 29.92% -58.20% 400.36% 36.58% -73.99%
Net Income Q/Q Growth
323.64% -230.24% 102.15% -84.86% -4,311.35% 336.71% -24.00% -18.40% 367.31% 37.17% -81.88%
EPS Q/Q Growth
325.00% -232.32% 103.05% -100.00% 0.00% 338.89% -23.26% -18.18% 374.07% 36.72% -81.71%
Operating Cash Flow Q/Q Growth
107.20% 430.00% -58.95% -59.93% 57.67% 67.46% -6.96% -8.15% -54.09% 216.03% 4.08%
Free Cash Flow Firm Q/Q Growth
18.65% 66.63% 5.33% 6.99% 8.30% -30.16% 2.21% -3.06% -23.16% -30.09% -6.99%
Invested Capital Q/Q Growth
0.87% -10.93% -3.30% -1.85% -2.05% -4.78% -3.71% -2.51% 3.66% -0.72% -6.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.38% 36.12% 40.58% 37.48% 42.55% 42.72% 42.16% 40.52% 46.96% 46.75% 48.87%
EBITDA Margin
21.38% 4.90% 13.66% 10.43% 9.67% 15.43% 12.19% 14.40% 22.70% 27.53% 12.65%
Operating Margin
13.72% -3.87% 3.19% 0.52% 0.92% 5.79% 3.25% 3.67% 14.90% 19.35% 3.90%
EBIT Margin
14.19% -2.44% 4.97% 1.85% 2.40% 7.37% 4.05% 6.16% 16.40% 20.93% 4.89%
Profit (Net Income) Margin
8.83% -11.82% 0.29% 0.05% -1.67% 4.50% 3.61% 3.13% 11.30% 16.52% 3.68%
Tax Burden Percent
69.86% 289.87% 9.27% -57.26% -696.56% 84.41% 206.04% 80.78% 77.12% 86.44% 137.07%
Interest Burden Percent
89.07% 167.08% 63.07% -4.42% 9.97% 72.38% 43.24% 62.78% 89.35% 91.33% 54.87%
Effective Tax Rate
30.14% 0.00% 90.73% 0.00% 796.56% 15.59% -106.04% 19.22% 22.88% 13.56% -37.07%
Return on Invested Capital (ROIC)
5.68% -1.91% 0.23% 0.31% -5.42% 4.30% 5.98% 2.66% 10.28% 15.72% 5.20%
ROIC Less NNEP Spread (ROIC-NNEP)
5.00% -11.51% 0.23% 0.05% -0.79% 3.86% 2.07% 2.88% 9.96% 15.26% 1.91%
Return on Net Nonoperating Assets (RNNOA)
1.49% -3.01% 0.06% 0.01% -0.23% 0.88% 0.41% 0.50% 1.83% 1.89% 0.23%
Return on Equity (ROE)
7.17% -4.91% 0.30% 0.32% -5.65% 5.18% 6.39% 3.17% 12.10% 17.62% 5.44%
Cash Return on Invested Capital (CROIC)
4.57% 12.36% 12.86% 15.26% 18.86% 12.94% 14.54% 15.72% 13.33% 12.36% 15.59%
Operating Return on Assets (OROA)
6.31% -1.23% 2.83% 1.13% 1.43% 4.41% 2.41% 3.62% 9.54% 12.91% 3.06%
Return on Assets (ROA)
3.92% -5.94% 0.17% 0.03% -1.00% 2.70% 2.15% 1.83% 6.57% 10.19% 2.30%
Return on Common Equity (ROCE)
7.17% -4.91% 0.30% 0.32% -5.65% 5.18% 6.39% 3.17% 12.10% 17.62% 5.44%
Return on Equity Simple (ROE_SIMPLE)
-2.63% -5.81% 0.00% -0.76% -4.14% 0.80% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
106 -29 2.78 3.22 -67 45 58 24 122 166 43
NOPAT Margin
9.59% -2.71% 0.30% 0.36% -6.44% 4.88% 6.69% 2.97% 11.49% 16.73% 5.34%
Net Nonoperating Expense Percent (NNEP)
0.69% 9.60% 0.00% 0.26% -4.63% 0.44% 3.91% -0.21% 0.31% 0.46% 3.29%
Return On Investment Capital (ROIC_SIMPLE)
- -0.51% - - - 0.91% 1.18% 0.49% 2.40% 3.17% 0.88%
Cost of Revenue to Revenue
55.62% 63.88% 59.42% 62.52% 57.45% 57.28% 57.84% 59.48% 53.04% 53.25% 51.13%
SG&A Expenses to Revenue
10.45% 8.54% -5.25% 15.80% 13.20% 17.38% -19.51% 8.01% 7.68% 4.49% 7.57%
R&D to Revenue
15.85% 15.30% 19.12% 21.16% 19.21% 19.55% 20.69% 21.89% 18.75% 17.93% 21.08%
Operating Expenses to Revenue
30.65% 39.99% 37.39% 36.96% 41.63% 36.93% 38.91% 36.85% 32.06% 27.40% 44.97%
Earnings before Interest and Taxes (EBIT)
157 -26 47 16 25 68 35 50 174 208 40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
236 53 129 93 101 141 106 118 240 273 102
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.45 3.01 3.12 3.18 2.88 2.00 1.97 2.27 2.46 2.15 2.14
Price to Tangible Book Value (P/TBV)
14.70 18.33 21.64 23.16 18.66 11.05 9.16 9.81 9.62 7.16 8.25
Price to Revenue (P/Rev)
2.99 3.17 2.94 2.77 2.49 1.78 1.80 2.14 2.35 2.13 1.95
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 250.18 120.07 96.54 39.57 23.36 21.15
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.40% 0.83% 1.04% 2.53% 4.28% 4.73%
Enterprise Value to Invested Capital (EV/IC)
2.08 2.60 2.72 2.75 2.51 1.85 1.84 2.15 2.30 2.09 2.05
Enterprise Value to Revenue (EV/Rev)
3.41 3.44 3.19 2.98 2.70 1.98 1.93 2.24 2.47 2.18 2.03
Enterprise Value to EBITDA (EV/EBITDA)
37.62 50.06 25.92 23.45 28.45 16.19 16.28 17.50 14.94 11.08 10.20
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 84.19 61.73 171.91 48.17 49.80 45.77 27.68 17.49 15.88
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 5,665.32 229.26 89.09 82.07 38.74 23.02 21.37
Enterprise Value to Operating Cash Flow (EV/OCF)
24.20 17.08 14.43 13.75 11.80 12.00 11.54 11.27 13.30 11.17 9.26
Enterprise Value to Free Cash Flow (EV/FCFF)
44.18 19.56 19.60 16.61 12.06 13.46 11.88 12.76 16.58 16.61 12.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.54 0.56 0.56 0.56 0.58 0.46 0.46 0.45 0.44 0.42 0.46
Long-Term Debt to Equity
0.54 0.43 0.44 0.44 0.45 0.46 0.46 0.45 0.44 0.42 0.46
Financial Leverage
0.30 0.26 0.28 0.29 0.30 0.23 0.20 0.18 0.18 0.12 0.12
Leverage Ratio
1.73 1.77 1.78 1.80 1.83 1.80 1.80 1.80 1.82 1.71 1.75
Compound Leverage Factor
1.54 2.95 1.12 -0.08 0.18 1.31 0.78 1.13 1.63 1.56 0.96
Debt to Total Capital
34.92% 35.82% 35.86% 36.00% 36.51% 31.43% 31.35% 31.07% 30.62% 29.52% 31.66%
Short-Term Debt to Total Capital
0.00% 8.47% 7.91% 7.56% 7.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
34.92% 27.35% 27.94% 28.44% 28.84% 31.43% 31.35% 31.07% 30.62% 29.52% 31.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
65.08% 64.18% 64.14% 64.00% 63.49% 68.57% 68.65% 68.93% 69.38% 70.48% 68.34%
Debt to EBITDA
7.23 8.54 4.29 3.85 5.23 3.34 3.51 3.32 2.56 2.10 2.11
Net Debt to EBITDA
4.64 3.93 2.02 1.67 2.24 1.63 1.14 0.78 0.71 0.29 0.43
Long-Term Debt to EBITDA
7.23 6.52 3.34 3.04 4.13 3.34 3.51 3.32 2.56 2.10 2.11
Debt to NOPAT
-38.03 -22.79 -22.68 -64.21 1,041.65 47.32 19.22 15.58 6.63 4.37 4.42
Net Debt to NOPAT
-24.43 -10.48 -10.67 -27.93 446.19 23.04 6.26 3.64 1.83 0.60 0.90
Long-Term Debt to NOPAT
-38.03 -17.40 -17.67 -50.73 822.75 47.32 19.22 15.58 6.63 4.37 4.42
Altman Z-Score
2.77 2.84 3.02 3.08 2.72 2.49 2.50 2.75 3.02 3.06 2.73
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.37 1.90 1.99 1.95 1.90 2.60 2.77 2.81 2.95 3.67 3.24
Quick Ratio
1.98 1.24 1.18 1.25 1.27 1.50 1.81 1.89 2.07 2.72 2.27
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
401 668 704 753 816 570 582 564 434 303 282
Operating Cash Flow to CapEx
404.16% 1,874.82% 660.95% 212.74% 403.11% 580.80% 835.15% 487.29% 200.95% 931.50% 0.00%
Free Cash Flow to Firm to Interest Expense
23.42 38.01 40.73 44.05 36.10 30.53 29.13 30.04 23.46 16.82 15.81
Operating Cash Flow to Interest Expense
5.43 28.04 11.71 4.74 5.66 11.48 9.97 9.74 4.54 14.73 15.49
Operating Cash Flow Less CapEx to Interest Expense
4.09 26.54 9.94 2.51 4.25 9.50 8.77 7.74 2.28 13.15 17.19
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.44 0.50 0.57 0.61 0.60 0.60 0.60 0.59 0.58 0.62 0.63
Accounts Receivable Turnover
4.86 7.58 9.94 10.44 6.50 7.95 9.01 9.32 6.35 7.80 9.24
Inventory Turnover
2.41 2.83 3.03 2.94 3.13 3.24 3.23 3.10 3.19 3.51 3.33
Fixed Asset Turnover
2.74 3.10 3.73 4.10 4.14 4.08 4.45 4.40 4.50 4.74 4.86
Accounts Payable Turnover
6.79 8.82 9.84 8.06 8.04 7.91 8.50 7.24 6.84 7.94 7.91
Days Sales Outstanding (DSO)
75.17 48.15 36.72 34.96 56.14 45.90 40.49 39.15 57.49 46.79 39.51
Days Inventory Outstanding (DIO)
151.16 129.06 120.58 124.32 116.64 112.69 112.97 117.69 114.25 104.09 109.54
Days Payable Outstanding (DPO)
53.74 41.40 37.10 45.26 45.39 46.15 42.93 50.41 53.33 45.96 46.17
Cash Conversion Cycle (CCC)
172.60 135.81 120.21 114.02 127.38 112.45 110.53 106.43 118.42 104.92 102.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,133 4,572 4,421 4,339 4,250 4,047 3,897 3,799 3,938 3,910 3,658
Invested Capital Turnover
0.59 0.70 0.79 0.85 0.84 0.88 0.89 0.90 0.89 0.94 0.97
Increase / (Decrease) in Invested Capital
-295 -697 -701 -750 -883 -525 -524 -540 -312 -137 -239
Enterprise Value (EV)
10,664 11,896 12,022 11,950 10,668 7,505 7,182 8,162 9,047 8,169 7,485
Market Capitalization
9,348 10,962 11,087 11,097 9,828 6,751 6,678 7,800 8,619 7,957 7,171
Book Value per Share
$38.99 $37.38 $36.84 $36.46 $35.95 $35.76 $36.32 $36.95 $37.88 $40.03 $36.07
Tangible Book Value per Share
$6.49 $6.14 $5.31 $5.01 $5.55 $6.46 $7.81 $8.55 $9.67 $12.03 $9.38
Total Capital
5,866 5,669 5,544 5,447 5,372 4,930 4,942 4,986 5,059 5,247 4,893
Total Debt
2,049 2,030 1,988 1,961 1,961 1,549 1,549 1,549 1,549 1,549 1,549
Total Long-Term Debt
2,049 1,550 1,549 1,549 1,549 1,549 1,549 1,549 1,549 1,549 1,549
Net Debt
1,316 934 936 853 840 754 505 362 428 212 314
Capital Expenditures (CapEx)
23 26 31 38 32 37 24 38 42 28 -30
Debt-free, Cash-free Net Working Capital (DFCFNWC)
884 556 625 491 514 520 363 282 469 489 375
Debt-free Net Working Capital (DFNWC)
1,591 1,628 1,655 1,574 1,611 1,289 1,384 1,448 1,572 1,807 1,594
Net Working Capital (NWC)
1,591 1,148 1,216 1,162 1,199 1,289 1,384 1,448 1,572 1,807 1,594
Net Nonoperating Expense (NNE)
8.32 98 0.04 2.81 -50 3.49 27 -1.29 2.00 2.02 13
Net Nonoperating Obligations (NNO)
1,316 934 865 853 840 667 505 362 428 212 314
Total Depreciation and Amortization (D&A)
79 79 82 76 76 74 71 67 67 66 63
Debt-free, Cash-free Net Working Capital to Revenue
28.24% 16.06% 16.59% 12.26% 13.03% 13.71% 9.76% 7.74% 12.80% 13.07% 10.18%
Debt-free Net Working Capital to Revenue
50.82% 47.04% 43.90% 39.29% 40.80% 34.01% 37.22% 39.66% 42.92% 48.33% 43.32%
Net Working Capital to Revenue
50.82% 33.17% 32.26% 29.00% 30.36% 34.01% 37.22% 39.66% 42.92% 48.33% 43.32%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.00 ($1.31) $0.03 $0.00 ($0.18) $0.44 $0.33 $0.28 $1.29 $1.77 $0.32
Adjusted Weighted Average Basic Shares Outstanding
97.95M 97.15M 97.56M 95.47M 94.89M 94.34M 94.59M 92.92M 92.80M 92.59M 92.59M
Adjusted Diluted Earnings per Share
$0.99 ($1.31) $0.04 $0.00 ($0.18) $0.43 $0.33 $0.27 $1.28 $1.75 $0.32
Adjusted Weighted Average Diluted Shares Outstanding
98.59M 97.15M 97.56M 96.51M 94.89M 95.03M 95.45M 93.77M 93.79M 93.57M 93.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
97.35M 96.55M 95.63M 94.86M 94.53M 93.40M 93.03M 92.65M 92.40M 92.71M 88.01M
Normalized Net Operating Profit after Tax (NOPAT)
139 92 21 3.22 74 45 20 24 122 166 22
Normalized NOPAT Margin
12.62% 8.59% 2.23% 0.36% 7.10% 4.88% 2.27% 2.97% 11.49% 16.73% 2.73%
Pre Tax Income Margin
12.64% -4.08% 3.14% -0.08% 0.24% 5.34% 1.75% 3.87% 14.65% 19.11% 2.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.15 -1.49 2.71 0.96 1.11 3.62 1.76 2.69 9.39 11.53 2.22
NOPAT to Interest Expense
6.18 -1.66 0.16 0.19 -2.98 2.40 2.91 1.29 6.58 9.21 2.42
EBIT Less CapEx to Interest Expense
7.80 -2.99 0.94 -1.27 -0.29 1.65 0.57 0.69 7.13 9.95 3.92
NOPAT Less CapEx to Interest Expense
4.83 -3.15 -1.61 -2.04 -4.39 0.42 1.72 -0.70 4.32 7.63 4.13
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-549.12% -212.82% -568.89% -1,614.13% -287.75% 1,505.90% 640.72% 348.18% 121.67% 53.57% 157.10%

Financials Breakdown Chart

Key Financial Trends

Qorvo’s latest quarter showed a sharp year-over-year recovery in profitability, but the broader trend over the last several years is still choppy. For Q4 2026, revenue came in at $808.3 million, down from $993.0 million in the prior quarter and $869.5 million a year ago, but the company still generated $29.7 million in net income. That compares with a loss in Q4 2025 and a much more volatile performance over the prior year.

The biggest positive takeaway is cash generation. Qorvo produced $276.3 million in operating cash flow in Q4 2026, and $276.3 million is substantial relative to the quarter’s $29.7 million in net income. That suggests the business is still converting earnings into cash reasonably well, even as revenue trends remain uneven.

However, profitability has been under pressure from both lower sales and high operating costs. In Q4 2026, gross margin was roughly 48.9% of revenue, but operating expenses still consumed most of that profit, leaving operating income of just $31.5 million. R&D alone was $170.4 million, underscoring the company’s heavy spending to support product development and competitiveness.

Balance sheet trends look mixed but manageable. As of Q3 2026, Qorvo held $1.32 billion in cash and equivalents against $1.55 billion in long-term debt, with total liabilities of $2.47 billion and equity of $3.70 billion. Liquidity appears solid, but the debt load remains meaningful and interest expense continues to eat into pre-tax income.

Over the last four years, Qorvo’s earnings profile has been highly cyclical. The company posted strong quarters in parts of 2022 and 2023, then swung into losses in several quarters of 2024 and 2025 before stabilizing again in 2026. That pattern tells investors that demand and margin conditions in Qorvo’s end markets can change quickly.

  • Operating cash flow remained strong at $276.3 million in Q4 2026, showing the business can still generate cash even in a softer sales environment.
  • The company returned to profitability in Q4 2026 with net income of $29.7 million, after periods of losses in prior quarters.
  • Cash and equivalents were high at $1.32 billion in Q3 2026, giving Qorvo a sizable liquidity cushion.
  • Book equity remains solid at $3.70 billion, which provides balance-sheet support.
  • Q4 2026 operating income was positive at $31.5 million, suggesting the core business still has earnings power.
  • Revenue is still volatile quarter to quarter. Q4 2026 revenue declined from the prior quarter and from the year-ago period.
  • R&D spending remains elevated. That can pressure margins, but it also supports product development in a competitive industry.
  • Debt remains material. Long-term debt of about $1.55 billion means interest costs will remain a factor.
  • Share repurchases continue. Qorvo used significant cash to buy back stock, which can support EPS but also reduces flexibility if conditions weaken.
  • Revenue has been inconsistent over the last several years. The company has not shown a smooth growth trajectory.
  • Operating margins have been under pressure in weaker periods, especially when impairment charges and lower revenue hit results.
  • Inventory has been elevated at times relative to recent revenue trends, which can be a sign of demand mismatch.
  • Interest expense continues to weigh on earnings and reduces the benefit of operating improvements.

Bottom line: Qorvo appears to be stabilizing after a volatile stretch, with better cash generation and a return to profitability in the latest quarter. Still, the long-term story is not yet one of consistent growth, and investors should watch whether revenue can re-accelerate while margins stay intact.

05/25/26 01:54 PM ETAI Generated. May Contain Errors.

Qorvo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Qorvo's financial year ends in March. Their financial year 2026 ended on March 28, 2026.

Qorvo's net income appears to be on an upward trend, with a most recent value of $338.99 million in 2026, falling from -$28.85 million in 2016. The previous period was $55.62 million in 2025. See Qorvo's forecast for analyst expectations on what's next for the company.

Qorvo's total operating income in 2026 was $411.42 million, based on the following breakdown:
  • Total Gross Profit: $1.69 billion
  • Total Operating Expenses: $1.28 billion

Over the last 10 years, Qorvo's total revenue changed from $2.61 billion in 2016 to $3.68 billion in 2026, a change of 40.9%.

Qorvo's total liabilities were at $2.48 billion at the end of 2026, a 2.3% decrease from 2025, and a 55.4% increase since 2016.

In the past 10 years, Qorvo's cash and equivalents has ranged from $425.88 million in 2016 to $1.40 billion in 2021, and is currently $1.22 billion as of their latest financial filing in 2026.

Over the last 10 years, Qorvo's book value per share changed from 36.47 in 2016 to 36.07 in 2026, a change of -1.1%.



Financial statements for NASDAQ:QRVO last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners